Business
RTP to be home to many of Gilead Sciences' operations
California-based Gilead Sciences, which makes the COVID-19 treatment remdesivir, announced Tuesday that it plans to open a major hub in the Triangle.
Details
Transcript
California-based Gilead Sciences, which makes the COVID-19 treatment remdesivir, announced Tuesday that it plans to open a major hub in the Triangle.
Reporter : Keely ArthurPhotographer : Kyle Gould
Web Editor : Matthew Burns
Posted 2021-02-09T19:57:43-0500 - Updated 2021-02-09T19:57:43-0500
